Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The TeGenero incident and the Duff Report conclusions: a series of unfortunate events or an avoidable event?

× No keyword cloud information.

11 in total

1. Pharmacokinetics and toxicology of therapeutic proteins: Advances and challenges.

Authors: Yulia Vugmeyster; Xin Xu; Frank-Peter Theil; Leslie A Khawli; Michael W Leach
Journal: World J Biol Chem Date: 2012-04-26

2. Preclinical development of monoclonal antibodies: considerations for the use of non-human primates.

Authors: Kathryn Chapman; Nick Pullen; Lee Coney; Maggie Dempster; Laura Andrews; Jeffrey Bajramovic; Paul Baldrick; Lorrene Buckley; Abby Jacobs; Geoff Hale; Colin Green; Ian Ragan; Vicky Robinson
Journal: MAbs Date: 2009-09-30 Impact factor: 5.857

3. Do we need a special ethics for research?

Authors: Sven Ove Hansson
Journal: Sci Eng Ethics Date: 2009-11-26 Impact factor: 3.525

4. Storm forecasting: additional lessons from the CD28 superagonist TGN1412 trial.

Authors: Christopher Horvath; Laura Andrews; Andreas Baumann; Lauren Black; Diann Blanset; Joy Cavagnaro; Kenneth L Hastings; David L Hutto; Timothy K MacLachlan; Mark Milton; Theresa Reynolds; Stan Roberts; Mark Rogge; Jennifer Sims; George Treacy; Garvin Warner; James D Green
Journal: Nat Rev Immunol Date: 2012-08-31 Impact factor: 53.106

5. Commentary on the EMA Guideline on strategies to identify and mitigate risks for first-in-human and early clinical trials with investigational medicinal products.

Authors: Joop van Gerven; Milton Bonelli
Journal: Br J Clin Pharmacol Date: 2018-05-30 Impact factor: 4.335

6. Immuno-Oncology: The Third Paradigm in Early Drug Development.

Authors: Juan Martin-Liberal; Cinta Hierro; Maria Ochoa de Olza; Jordi Rodon
Journal: Target Oncol Date: 2017-04 Impact factor: 4.493

Review 7. Pharmacokinetics and pharmacodynamics of rilotumumab: a decade of experience in preclinical and clinical cancer research.

Authors: Y Zhang; S Doshi; M Zhu
Journal: Br J Clin Pharmacol Date: 2015-05-26 Impact factor: 4.335

The TeGenero incident and the Duff Report conclusions: a series of unfortunate events or an avoidable event?